“We have the champions”, the conference about the pharmaceutical industrial system in Germany, has taken place in the German Federal Ministry of Health this morning.
The meeting was attended by many representatives of German pharmaceutical companies. Chancellor Angela Merkel (CDU) and Health Minister Philippe Rösler also spoke at the conference.
A lot of expectation was placed in the event after a statement from the Health Minister Philipp Roesler, who said on Wednesday that the cost freeze
and other measures are intended to give the government time for an overhaul of Germany's pharmaceutical market regulations.
Though the German market is already tightly regulated, prices are higher than in many other countries. In 2009 the mandatory health insurance covering about 90 percent of all Germans and saw a cost increase by 5.3 percent.
Federal Health Minister Philipp Rösler (FDP) has stated the health industry is a "guarantee for the employment’s market."
“About 4.6 million people are actually working in the pharmaceutical industry,” the Minister said. “It means11.5 percent of the total.”
Rösler said he expects that this amount will be at 20 percent in 2030. The industry has an annual business of 260 billion euros.
Chancellor Angela Merkel (CDU) said at the Congress that the issue of health has a strong importance for the future and for the economic strength of Germany.
“In the health industry,” continues the German Chancellor, “there is a great potential for employment and very good sales prospects. It would be ridiculous if Germany could not participate in it.”
"We have to strengthen all areas where the growth is possible," concluded Merkel.